EVAR with No Complications in Octogenarians: Survival Rate Identical to that of Healthy Octogenarians

This analysis reports (for the first time in the literature) that after the endovascular aortic aneurysm repair (EVAR) in octogenarians, survival rate is the same as that of their healthy counterparts.  

Pacientes que no siguen nuestro consejo y sorpresivamente tienen menos eventos

This is true provided the procedure does not present complications. If any, mortality results twice as high in this group. 

Using propensity score, researchers compared octogenarians with identical comorbidities undergoing EVAR vs. others with no aortic aneurysm from the Rotterdam study.

Complications rate for this procedure resulted 27% (mainly cardiac, pulmonary and access complications). This represents twice as many complications than in younger patients, which emphasizes the importance of correct patient selection.


Read also: Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?


After uncomplicated EVAR, mortality results similar vs the control group in the Rotterdam trial (HR 1.09, CI 95% 0.68 to 1.77). However, should there be any complications, these figures would see a dramatic change (HR 1.93, CI 95% 1.06 to 3.54).

Conclusion

After uncomplicated EVAR in 80+ patients, survival rate is the same as their healthy contemporaries. 

Patient selection and perioperatory care should be carried out thoroughly. 

Original Title: Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic Aneurysm.

Reference: Oscar L. Rueda-Ochoa et al. Eur J Vasc Endovasc Surg, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....